You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 114 No. 8, August 1996 TABLE OF CONTENTS
  Archives
  •  Online Features
  CLINICAL SCIENCES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Corneal Sensitivity and Burning Sensation

Comparing Topical Ketorolac and Diclofenac

Berthold Seitz, MD; Kris Sorken; Laurie D. LaBree, MS; Jenny J. Garbus; Peter J. McDonnell, MD

Arch Ophthalmol. 1996;114(8):921-924.


Abstract

Objectives
To compare the effect of topical 0.5% ketorolac tromethamine and 0.1% diclofenac sodium on human corneal sensitivity and to assess the intensity of burning sensation at specific intervals after drop instillation.

Design and Setting
Double-masked parallel clinical study.

Patients
Eleven women and 4 men (8 white, 4 Hispanic, 3 Asian), 22 to 60 years of age (mean[±SD], 34±10 years).

Interventions
Repeated instillation of either ketorolac and placebo or diclofenac and placebo at 5-minute intervals.

Main Outcome Measures
Assessment of corneal sensitivity before instillation, immediately after instillation, and after termination of drop application; and subjective evaluation of burning sensation by asking participants to rate burning on a scale ranging from 0 (none) to 3 (severe) after each drop application.

Results
Both diclofenac (P<.01) and ketorolac (P<.01) decreased corneal sensitivity significantly, while the placebo had no measurable effect. After administration of additional drops over time, the effect of diclofenac and ketorolac increased. After termination of the drug instillation, corneal sensitivity returned to baseline significantly slower (P<.01) in participants receiving diclofenac than in those receiving ketorolac. Ketorolac (P=.01) and diclofenac (P<.05) were significantly more effective in whites than in nonwhites. Mean burning sensation was mild, and there was no statistically significant difference between the 2 drugs on this measure (P=.12).

Conclusions
The decrease in corneal sensitivity in normal human corneas is more pronounced and longer lasting with diclofenac than with ketorolac. Both drugs are well tolerated topically and may be useful for pain reduction after refractive corneal surgery.



Author Affiliations

From the Doheny Eye Institute (Drs Seitz and McDonnell and Mss Sorken and Garbus), and the Departments of Ophthalmology and Preventive Medicine (Ms LaBree), University of Southern California School of Medicine, Los Angeles; and the Department of Ophthalmology and Eye Hospital, University of Erlangen-Nürnberg, Erlangen, Germany (Dr Seitz).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Comparative Effects of the Nonsteroidal Anti-inflammatory Drug Nepafenac on Corneal Sensory Nerve Fibers Responding to Chemical Irritation
Acosta et al.
IOVS 2007;48:182-188.
ABSTRACT | FULL TEXT  

Corneal Melting Associated With Use of Topical Nonsteroidal Anti-inflammatory Drugs After Ocular Surgery
Lin et al.
Arch Ophthalmol 2000;118:1129-1132.
FULL TEXT  

Topical analgesia during retinal laser photocoagulation
KWOK et al.
Br J Ophthalmol 2000;84:936e-936.
FULL TEXT  

Analgesic effect of topical sodium diclofenac 0.1% drops during retinal laser photocoagulation
Weinberger et al.
Br J Ophthalmol 2000;84:135-137.
ABSTRACT | FULL TEXT  

Topical 0.5% Ketorolac vs 0.03% Flurbiprofen for Inhibition of Miosis During Cataract Surgery
Solomon et al.
Arch Ophthalmol 1997;115:1119-1122.
ABSTRACT  

Corneal Sensitivity Debate
Villain et al.
Arch Ophthalmol 1997;115:686-686.
ABSTRACT  

Corneal Sensitivity Debate-Reply
Seitz and McDonnell
Arch Ophthalmol 1997;115:686-686.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1996 American Medical Association. All Rights Reserved.